In the wire
EssilorLuxottica: EssilorLuxottica Board of Directors unanimously reaffirms confidence in the Company’s leadership and strategy
Sep 9 · 13:15GlobeNewswire
Il Consiglio di Amministrazione di EssilorLuxottica conferma all’unanimità piena fiducia nella leadership e nella strategia del Gruppo
Le Conseil d’administration d’EssilorLuxottica réaffirme à l’unanimité sa confiance dans le management et la stratégie de l’entreprise
With registration open and the program set, the inaugural AISBA has drawn sponsors and speakers from across a cross-section of industries — including Amazon Web Services, FAA, World Fuel, and Signature Aviation— reflecting the immediate need for practical guidance on AI, says co-host....
Company issues only 11,282 shares through DTC to address fractional-share rounding; no other shares issued in connection with the reverse split
Integration links IMTC's platform with MarketAxess' global electronic trading network to help institutions trade more efficiently and improve execution quality. NEW YORK, Sept. 9, 2026 /PRNewswire-PRWeb/ -- IMTC, the fixed income technology platform trusted by buy‑side portfolio managers,...
SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 22,250,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $12.35 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”) from certain stockholders of the Company (the “Selling Stockholders”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds
New Green Hemp Announces Leadership Realignment, EcoGreen Development Priorities and Capital Planning Update
Paychex Schedules First Quarter Fiscal 2027 Earnings Conference Call on September 23, 2026
SARASOTA, FLA., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), ”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a wholly owned managed AI agent platform, today announced that company representatives will participate in the upcoming IPAC-RS 2026 Nasal Innovation Forum to be held September 16-17, 2026, in Jersey City, New Jersey.
Noida, India, 2026-09-09 — /EPR Network/ — Modern energy infrastructure is undergoing a significant transformation as power systems become more decentralized, digital, and resilient. Growing [read full press release...]
The Lewes-based integrative medicine practice adds EMSCULPT NEO, EMSELLA, EMVITAL, and EXOMIND to its offerings, the next step in Dr. Jani's decades-long mission to help patients get and stay, well, naturally LEWES, Del., Sept. 9, 2026 /PRNewswire-PRWeb/ -- Shore View Wellness, a Lewes,...